ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Moonwalk Biosciences raised $70 million in Series B financing. The funding round supports the company's continued development of its epigenetic editing platform. The new capital advances Moonwalk's therapeutic programs and operational growth.
Tap to vote and see what everyone thinks.
Summary by ByteBrief